(Q39112597)

9 September 2017

The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer (English)

1 reference

9 September 2017

1 reference

Furong Dai

1

1 reference

9 September 2017

Yi Zhang

2

1 reference

9 September 2017

Xin Zhu

3

1 reference

9 September 2017

Nianchun Shan

4

1 reference

9 September 2017

Yuxiang Chen

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

8 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

131

1 reference

9 September 2017

2

1 reference

9 September 2017

451-459

1 reference

Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX.

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Designing early detection programs for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Targeted therapy in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Ovarian cancer stem cells and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Ovarian cancer: advances in first-line treatment strategies with a particular focus on anti-angiogenic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Role for a bidentate ribonuclease in the initiation step of RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Structural basis for double-stranded RNA processing by Dicer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Growth factor signaling and resistance to cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

The gastrointestinal tract stem cell niche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Treatment resistance in stem cells and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Cancerous stem cells can arise from pediatric brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

ALDH1 as a functional marker of cancer stem and progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Methylation profile in benign, borderline and malignant ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

The resurgence of platinum-based cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

PTEN, more than the AKT pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

PI3K/Akt: getting it right matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

The complexity of PTEN: mutation, marker and potential target for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.112

10.1016/J.YGYNO.2013.07.112

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference